BlueSphere Bio was founded to unlock the potential of personalized T cell therapy for the treatment of cancer by harnessing the unique specificity of each patient’s own T cells for the particular molecular fingerprint of each patient’s own cancer through our novel TCXpress technology. Our proprietary TCXpress platform is an elegant, rapid approach that exploits the patient’s own immune defenses to attack their cancer specifically, and is designed to leave normal tissues untouched, thereby reducing harmful side effects. The platform and implementation allows us to deliver rapid, personalized T cell treatments for a variety of cancer indications.
View Top Employees from BlueSphere BioWebsite | https://www.bluespherebio.com/ |
Revenue | $405000 |
Funding | $45 million |
Employees | 64 (64 on RocketReach) |
Founded | 2018 |
Address | 350 Technology Drive Suite 520, Pittsburgh, Pennsylvania 15221, US |
Technologies |
HTML,
Nginx,
Microsoft Outlook
+2 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular BlueSphere Bio employee's phone or email?
The BlueSphere Bio annual revenue was $405000 in 2024.
Warren Shlomchik is the Co-Founder of BlueSphere Bio.
64 people are employed at BlueSphere Bio.
BlueSphere Bio is based in Pittsburgh, Pennsylvania.
The NAICS codes for BlueSphere Bio are [541714, 5417, 54171, 541, 54].
The SIC codes for BlueSphere Bio are [87, 873].